Literature DB >> 10708517

A transcript map of the chromosome 19q-arm glioma tumor suppressor region.

J S Smith1, I Tachibana, U Pohl, H K Lee, U Thanarajasingam, B P Portier, K Ueki, S Ramaswamy, S J Billings, H W Mohrenweiser, D N Louis, R B Jenkins.   

Abstract

Allelic loss of the chromosome 19q arm is a frequent event in human diffuse gliomas, suggesting that it contains a tumor suppressor gene. Recent deletion mapping studies have broadly implicated a 1.6-Mb interval between D19S241E and D19S596, with a limited subset of tumors, suggesting that the region may be as narrow as 150 kb. Focusing on this smaller interval, we have used cDNA selection, exon amplification, and genomic sequencing to identify three novel transcripts (EHD2, GLTSCR1, and GLTSCR2) and to map two known genes (SEPW1 and CRX). A partial transcript map of 19 transcripts and two EST markers has been constructed for the 1.6-Mb interval D19S241E-D19S596. Ten of these transcripts, including the 5 mapped to the 150-kb deletion interval, have been examined for alterations in a panel of gliomas with allelic loss of 19q. Tumor-specific alterations have not been identified in the transcripts examined thus far. Collectively, these data should facilitate subsequent efforts to identify and characterize the remaining transcripts in the 1.6-Mb interval. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708517     DOI: 10.1006/geno.1999.6101

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  54 in total

1.  Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation.

Authors:  Fumiaki Okahara; Kouichi Itoh; Akira Nakagawara; Makoto Murakami; Yasunori Kanaho; Tomohiko Maehama
Journal:  Mol Biol Cell       Date:  2006-09-13       Impact factor: 4.138

2.  High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.

Authors:  Xiaoming Ma; Tao Du; Dingjun Zhu; Xianju Chen; Yiming Lai; Wanhua Wu; Qiong Wang; Chunhao Lin; Zean Li; Leyuan Liu; Hai Huang
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

3.  A ribosomal tactic to halt cancer.

Authors:  Hua Lu
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

4.  DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma.

Authors:  Guanqian Yuan; Dandan Gao; Shaofeng Ding; Jun Tan
Journal:  Tumour Biol       Date:  2014-01-23

5.  Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.

Authors:  Lei Hui; Shuangzhu Yue; Guojun Gao; Haigang Chang; Xiangsheng Li
Journal:  Tumour Biol       Date:  2014-05-01

6.  GLTSCR2/PICT1 links mitochondrial stress and Myc signaling.

Authors:  John C Yoon; Alvin J Y Ling; Meltem Isik; Dong-Young Donna Lee; Michael J Steinbaugh; Laura M Sack; Abigail N Boduch; T Keith Blackwell; David A Sinclair; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

7.  Tumor prognostic factors and the challenge of developing predictive factors.

Authors:  Emma B Holliday; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

Review 8.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

9.  Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.

Authors:  Lei Zhang; James J Farrell; Hui Zhou; David Elashoff; David Akin; No-Hee Park; David Chia; David T Wong
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

Review 10.  PTEN and the PI3-kinase pathway in cancer.

Authors:  Nader Chalhoub; Suzanne J Baker
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.